University of Exeter
Contact by phone
Areas of expertise
Child Health, Complex Systems, Behaviour Change
Associate Professor of Health ResearchEmail me
This learning has also led to the development of a novel school-based behaviour change intervention to prevent childhood obesity, the Healthy Lifestyles Programme. £1.35million was secured from NIHR to determine the effectiveness and cost-effectiveness of HeLP in a 32 school cluster RCT involving 1300 children.
Project aims to To develop and explore the effect of a whole-system Wellbeing on Ward (WoW) intervention framework to improve staff health and wellbeing of NHS ward staff.
A cluster randomised controlled trial, economic and process evaluation to determine the effectiveness and cost effectiveness of HeLP in preventing childhood overweight and obesity.
Connecting Communities: Research towards a leading edge theory & practice for Community Engagement. The objective of our research was to identify the initial conditions that facilitated the creation of enabling environments for community engagement.
Behavioural and weight status outcomes from an exploratory trial of the Healthy Lifestyles Programme (HeLP): a novel school-based obesity prevention programme
Evidence, theory and context - using intervention mapping to develop a school-based intervention to prevent obesity in children
Is the Healthy Lifestyle Programme an acceptable and feasible school-based intervention to prevent obesity? (Poster)
Qualitative findings from an exploratory trial of the Healthy Lifestyles Programme (HeLP) and their implications for the process evaluation in the definitive trial
The development of a complex intervention for preventing childhood obesity: The Healthy Lifestyles Programme (HeLP) (Poster)
The Healthy Lifestyles Programme (HeLP) – An overview of and recommendations arising from the conceptualization and development of an innovative approach to promoting healthy lifestyles for children and their families.
The NCS-LSD cohort study: a description of the methods and analyses used to assess the long-term effectiveness of enzyme replacement therapy and substrate reduction therapy in patients with Lysosomal Storage Disorders